NL7101283A - Anorexic 1-phenoxy-2-amino-alkanes - Google Patents

Anorexic 1-phenoxy-2-amino-alkanes

Info

Publication number
NL7101283A
NL7101283A NL7101283A NL7101283A NL7101283A NL 7101283 A NL7101283 A NL 7101283A NL 7101283 A NL7101283 A NL 7101283A NL 7101283 A NL7101283 A NL 7101283A NL 7101283 A NL7101283 A NL 7101283A
Authority
NL
Netherlands
Prior art keywords
anorexic
alkanes
phenoxy
amino
alkyl
Prior art date
Application number
NL7101283A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL7101283A priority Critical patent/NL7101283A/en
Publication of NL7101283A publication Critical patent/NL7101283A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compounds (I) :- where R1 = H or C1-3 alkyl R2 = H or C1-4 alkyl R3 = cyano or a 3,4-methylenedioxy gp., and physiologically acceptable acid addn. salts thereof. Anorectics without CNS stimulating side-effects. Unit dosage for oral administration is 10-250 mg. (pref. 20-100 mg.).
NL7101283A 1971-02-01 1971-02-01 Anorexic 1-phenoxy-2-amino-alkanes NL7101283A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7101283A NL7101283A (en) 1971-02-01 1971-02-01 Anorexic 1-phenoxy-2-amino-alkanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7101283A NL7101283A (en) 1971-02-01 1971-02-01 Anorexic 1-phenoxy-2-amino-alkanes

Publications (1)

Publication Number Publication Date
NL7101283A true NL7101283A (en) 1971-05-25

Family

ID=19812379

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7101283A NL7101283A (en) 1971-02-01 1971-02-01 Anorexic 1-phenoxy-2-amino-alkanes

Country Status (1)

Country Link
NL (1) NL7101283A (en)

Similar Documents

Publication Publication Date Title
FI920956A0 (en) DOSERINGSFORM FOER ADMINISTRERING AV ORAL HYPOGLYKEMISK GLIPISID.
EP0567201A3 (en) Vehicles for oral administration of a specific pharmaceutically active acid labile substance.
ES2040232T3 (en) MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA.
NO177177C (en) Process for the preparation of a liquid dosage form for oral administration of a pharmaceutical substance
ATE211387T1 (en) ORAL 1ALPHA-HYDROXYPREVITAMIN D
OA09144A (en) Improved interferon therapy.
FI891774A0 (en) Process for preparing a form of administration and / or dosage form of a drug
IE42950L (en) X-ray contrast preparations
ES277844U (en) Dosing tip.
NL7101283A (en) Anorexic 1-phenoxy-2-amino-alkanes
BE827595A (en) MEDICINAL PRODUCT FOR ORAL ADMINISTRATION PRODUCING AN ANTIPLASMINE INHIBITOR EFFECT
ES2108680T3 (en) USE OF THE N-N-BUTYL DERIVATIVE OF DESOXINOJIRIMICINA IN THE MANUFACTURE OF A MEDICINAL PRODUCT.
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
MY101916A (en) Etoposide oral dosage form.
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
DE3871012D1 (en) THERAPEUTIC AGENTS CONTAINING ENANTIOMERS OF PROPAFENON.
FR2230338A1 (en) Masticatory compsn. contg. medicaments - for treatment of the mouth, throat, teeth, etc.
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
FR2132601A1 (en) Anti-alcoholic compsns contng calcium 5-buty
NL7104752A (en) Anti-alcoholic compsns contng calcium 5-buty
BE765809A (en) Anti-alcoholic compsns contng calcium 5-buty
OA03952A (en) A process for the preparation of a medicament containing oral immunizing substances.
FR2414507A1 (en) Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone
FR2085651A1 (en) 4-(2-(p-chlorophenoxy)-2-methylpropionyloxymethyloxazolines - with hypolipaemic and hypocholesterolaemic activity
FR2197599A1 (en) Substd piperidine anti-depressant compsns - contg 4-(4-acetyl phenyl)-piper-idine